tallózása szerző szerint "Lionetti P"

A találatok rendezése: Rendezés: Találatok:

  • ESPGHAN Revised Porto Criteria for the Diagnosis of Inflammatory Bowel Disease in Children and Adolescents. 
    Levine A; Koletzko S; Turner D; Escher JC; Cucchiara S; de Ridder L; Kolho KL; Veres, Gábor; Russell RK; Paerregaard A; Buderus S; Greer ML; Dias JA; Veereman-Wauters G; Lionetti P; Sladek M; Carpi JM; Staiano A; Ruemmele FM; Wilson DC (2014)
    BACKGROUND:: The diagnosis of pediatric-onset IBD (PIBD) can be challenging in choosing the most informative diagnostic tests and correctly classifying PIBD into its different subtypes. Recent advances in our understanding ...
  • Limitations of fecal calprotectin at diagnosis in untreated pediatric Crohn's Disease 
    Shaoul R; Sladek M; Turner D; Paeregaard A; Veres, Gábor; Wauters GV; Escher J; Dias JA; Lionetti P; Staino A; Kolho KL; de Ridder L; Nuti F; Cucchiara S; Sheva O; Levine A; ESPGHAN Porto IBD Group (2012)
    BACKGROUND: Fecal Calprotectin (FC) is a validated screening test for intestinal inflammation in Crohn's disease (CD). The objective of the study was to prospectively evaluate the limitations of FC for identifying CD in ...
  • Malignancy and Mortality in Pediatric Patients with Inflammatory Bowel Disease: A Multinational Study from the Porto Pediatric IBD Group. 
    de Ridder L; Turner D; Wilson DC; Koletzko S; Martin-de-Carpi J; Fagerberg UL; Spray C; Sladek M; Shaoul R; Roma-Giannikou E; Bronsky J; Serban DE; Cucchiara S; Veres, Gábor; Ruemmele FM; Hojsak I; Kolho KL; Davies IH; Aloi M; Lionetti P; Veereman-Wauters G; Braegger CP; Trindade E; Wewer AV; Hauer A; Levine A (2014)
    BACKGROUND: The combination of the severity of pediatric-onset inflammatory bowel disease (IBD) phenotypes and the need for intense medical treatment may increase the risk of malignancy and mortality, but evidence regarding ...